Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06471127 · ClinicalTrials.gov registry record · NA

Neuroplasticity Biomarkers in Aphasia

A NA study of Stroke and Aphasia, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06471127 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 90 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06471127, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Patients with stroke frequently suffer from aphasia, a disorder of expressive and/or receptive language, that can lead to serious health consequences, including social isolation, depression, reduced quality of life, and increased caregiver burden. Aphasia recovery varies greatly between individuals, and likely relies upon the capacity for neuroplasticity, both at a systems level of reorganized brain networks and a molecular level of neuronal repair and plasticity. The proposed work will evaluate genetic and neural network biological markers of neuroplasticity associated with variability in aphasia, with a future goal to improve prognostics and identify therapeutic targets to reduce the long-term burdens of aphasia.

Interventions

  • BEHAVIORAL Pseudoword learning paradigm task

Study Locations (1)

Wisconsin

  • UW School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-03-17
Est. Completion 2029-05-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06471127

The ClinicalTrials.gov registry entry for NCT06471127 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Pseudoword learning paradigm task is the first listed.

NCT06471127 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06471127 about?

NCT06471127 is a clinical study titled "Neuroplasticity Biomarkers in Aphasia". Patients with stroke frequently suffer from aphasia, a disorder of expressive and/or receptive language, that can lead to serious health consequences, including social isolation, depression, reduced quality of life, and increased caregiver burden. Aphasia recovery varies greatly between individuals,...

What is the current status of trial NCT06471127?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-03-17. Estimated completion is 2029-05-31.

What conditions does trial NCT06471127 study?

This clinical trial studies the following conditions: Stroke, Aphasia, Language.

What interventions are being tested in trial NCT06471127?

The interventions under investigation include: Pseudoword learning paradigm task (BEHAVIORAL).

Who is sponsoring clinical trial NCT06471127?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06471127 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.